SnapShot: Chronic Lymphocytic Leukemia
Copyright policy )SnapShot: Chronic Lymphocytic Leukemia
Despite the recent advances in the therapeutic management of Chronic Lymphocytic Leukemia (CLL) patients, this common B cell malignancy still remains incurable. This SnapShot provides an overview of CLL biology and therapy, with a focus on genetics and microenvironmental interactions, which contribute to disease progression and therapy resistance. To view this SnapShot, open or download the PDF.
- Dana-Farber Cancer Institute United States
- Clermont Université France
- Harvard Medical School United States
- Broad Institute United States
- Harvard University United States
[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematology, B-Lymphocytes, Models, Genetic, Leukemia, Lymphocytic, Chronic, B-Cell, Mutation, Disease Progression, Tumor Microenvironment, Humans, Genetic Predisposition to Disease, Signal Transduction
[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematology, B-Lymphocytes, Models, Genetic, Leukemia, Lymphocytic, Chronic, B-Cell, Mutation, Disease Progression, Tumor Microenvironment, Humans, Genetic Predisposition to Disease, Signal Transduction
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).9 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!